ABLYNX KONDIGT UITOEFENING WARRANTS AAN
April 30, 2018 01:16 ET
|
Ablynx NV
GEREGLEMENTEERDE INFORMATIE GENT, België, 30 april 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] kondigde vandaag aan, in overeenstemming met titel II van de Wet van 2 mei 2007 en het...
ABLYNX ANNOUNCES WARRANT EXERCISE
April 30, 2018 01:16 ET
|
Ablynx NV
REGULATED INFORMATION GHENT, Belgium, 30 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14...
OPENBAARMAKING IN OVEREENSTEMMING MET ARTIKEL 14 VAN DE BELGISCHE WET VAN 2 MEI 2007 BETREFFENDE DE OPENBAARMAKING VAN BELANGRIJKE DEELNEMINGEN (DE "TRANSPARANTIEWET")
April 30, 2018 01:11 ET
|
Ablynx NV
GEREGLEMENTEERDE INFORMATIE GENT, België, 30 april 2018 - Ablynx [Euronext Brussels en Nasdaq: ABLX] maakte vandaag bekend, in overeenstemming met artikel 14 van de Belgische wet van 2 mei 2007...
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
April 30, 2018 01:11 ET
|
Ablynx NV
REGULATED INFORMATION GHENT, Belgium, 30 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the...
ABLYNX VOLTOOIT PATIENTENRECRUTERING IN DE FASE IIb RESPIRE STUDIE MET HAAR GEINHALEERD ANTI-RSV NANOBODY ALX-0171
April 30, 2018 01:01 ET
|
Ablynx NV
GEREGLEMENTEERDE INFORMATIE - VOORWETENSCHAP GENT, België, 30 april 2018 - Ablynx [Euronext Brussels en Nasdaq: ABLX] deelde vandaag mee dat het met succes de patiëntenrecrutering heeft afgerond...
ABLYNX COMPLETES PATIENT RECRUITMENT IN THE PHASE IIb RESPIRE STUDY OF ITS INHALED ANTI-RSV NANOBODY ALX-0171
April 30, 2018 01:01 ET
|
Ablynx NV
REGULATED INFORMATION - INSIDE INFORMATION GHENT, Belgium, 30 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced that it has successfully completed patient recruitment in the...
OPENBAARMAKING IN OVEREENSTEMMING MET ARTIKEL 14 VAN DE BELGISCHE WET VAN 2 MEI 2007 BETREFFENDE DE OPENBAARMAKING VAN BELANGRIJKE DEELNEMINGEN (DE "TRANSPARANTIEWET")
April 24, 2018 01:01 ET
|
Ablynx NV
GEREGLEMENTEERDE INFORMATIE GENT, België, 24 april 2018 - Ablynx [Euronext Brussels en Nasdaq: ABLX] maakte vandaag bekend, in overeenstemming met artikel 14 van de Belgische wet van 2 mei 2007...
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
April 24, 2018 01:01 ET
|
Ablynx NV
REGULATED INFORMATION GHENT, Belgium, 24 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the...
OPENBAARMAKING IN OVEREENSTEMMING MET ARTIKEL 14 VAN DE BELGISCHE WET VAN 2 MEI 2007 BETREFFENDE DE OPENBAARMAKING VAN BELANGRIJKE DEELNEMINGEN (DE "TRANSPARANTIEWET")
April 19, 2018 01:06 ET
|
Ablynx NV
GEREGLEMENTEERDE INFORMATIE GENT, België, 19 april 2018 - Ablynx [Euronext Brussels en Nasdaq: ABLX] maakte vandaag bekend, in overeenstemming met artikel 14 van de Belgische wet van 2 mei 2007...
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
April 19, 2018 01:06 ET
|
Ablynx NV
REGULATED INFORMATION GHENT, Belgium, 19 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the...